Does low bioavailable and free testosterone reduce muscle protein synthesis and post-meal glucose disposal?

Aging is frequently accompanied by a decline in bioavailable and free testosterone, which triggers a downstream metabolic cascade that impairs both skeletal muscle preservation and systemic glucose regulation.

Testosterone and muscle protein synthesis

• Impaired anabolic signaling: Active free and bioavailable testosterone stimulates key intracellular pathways—specifically the AKT-mTORC1 and IGF-1 systems—to upregulate myogenic gene programming and translational efficiency.
• Negative protein balance: A deficit in these active androgens prevents anabolic priming, reducing resting and exercise-induced muscle protein fractional synthetic rates (FSR). When synthesis rates fall below baseline breakdown rates, chronic negative protein balance occurs, driving muscle atrophy and the progression of sarcopenia.

Muscle mass and glucose disposal

• Loss of the primary glucose sink: Skeletal muscle is the primary destination for circulating glucose. It is responsible for approximately 26% to 40% of glucose clearance under typical postprandial conditions, and up to 70% to 80% under peak insulin-stimulated conditions.
• Blunted GLUT4 translocation: A loss of skeletal muscle mass physically reduces the available surface area and the absolute pool of glucose transporter type 4 (GLUT4) proteins. This reduction, combined with impaired intracellular insulin signaling, blunts GLUT4 translocation to the cell membrane, restricting glucose entry and leading to impaired postprandial glycemic control.

Bottom line

• Low bioavailable and free testosterone levels impair muscle protein synthesis via reduced anabolic signaling, accelerating lean muscle loss. Because skeletal muscle serves as the primary reservoir for postprandial glucose clearance, this reduction in muscle mass diminishes the total available GLUT4 pool, directly limiting glucose disposal capacity and worsening post-meal blood sugar regulation.